|Bid||59.69 x 800|
|Ask||59.70 x 1000|
|Day's Range||59.52 - 60.44|
|52 Week Range||57.04 - 85.97|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||59.25|
|Earnings Date||Feb 02, 2021 - Feb 08, 2021|
|Forward Dividend & Yield||2.72 (4.51%)|
|Ex-Dividend Date||Dec 14, 2020|
|1y Target Est||73.72|
If you reinvest your recurring dividend payment along the way, those returns can grow even faster. Three stocks that you can buy today at some pretty low prices and that pay more than the average S&P 500 yield of 2% include Gilead Sciences (NASDAQ: GILD), Enbridge (NYSE: ENB), and the Kellogg Company (NYSE: K). Gilead has been an intriguing coronavirus stock, enjoying lots of optimism surrounding its antiviral drug, remdesivir.
The Zacks Analyst Blog Highlights: Gilead, Eli Lilly, Incyte and Pfizer
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD, PhD, Chief Medical Officer, will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2 at 11:20 a.m. Eastern Time.